Little-known treatment could save lives
In light of National Autoimmune Disease Awareness Month, author Julia Schopick points to a little-known yet proven treatment for autoimmune diseases that could save millions of lives and hundreds of millions of dollars in healthcare costs. It’s called Low Dose Naltrexone (LDN). “Most doctors and patients don’t even know about it,” said Schopick.
Schopick is the author of a blockbuster book on innovative medical treatments, Honest Medicine, and she’s an in-demand radio guest and patient coach. She was driven to search for better treatments after her husband was diagnosed with a malignant brain tumor decades ago. Inspired by his survival years beyond his doctor’s predictions, she saw firsthand just how effective treatments can be—and how important it is to get the word out about them. She’s now a passionate expert on a whole range of low-cost, non-toxic effective treatments “as well as the truth behind why doctors don’t prescribe many of them. LDN has had tremendous success treating people with many autoimmune diseases. In fact, it’s so promising that patients themselves underwrote a medical study, yet doctors as well as patients are often in the dark,” she adds.
Autoimmune diseases affect more than 50 million Americans and exceed $100 billion in direct healthcare costs every year. The drugs commonly used to treat these diseases—a “terrible hundred” that includes multiple sclerosis, lupus, rheumatoid arthritis, fibromyalgia and Crohn’s disease—are expensive, often ineffective, and wreak havoc on patients, often with damaging side effects. For 30 years LDN has proven effective against these diseases, according to Schopick.
“What keeps it on the outskirts of our awareness?” asked Schopick. “A terrible medical catch-22, in which most doctors only prescribe the drugs that are manufactured and marketed by pharmaceutical companies who have a stranglehold on the megastudies used for FDA approval.”
Patient education has never been so important—and no more so than with autoimmune diseases, according to Schopick. But there’s good news: a growing network of patients are learning about LDN and trying to break through the wall between Big Pharma and a known solution.
Visit the author’s website www.honestmedicine.com for more information.
